TaiMed Biologics Cash Flow Quality Index

Latest as of March 2026: -2.75x

TaiMed Biologics cash flow quality index. TaiMed Biologics (4147) has a Cash Flow Quality Index of -2.75x as of March 2026. Operating cash flow of NT$-45.01 Million is below net income of NT$16.35 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore TaiMed Biologics debt service capacity to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-2.75x

Operating CF / Net Income

Operating Cash Flow

NT$-45.01 Million

TWD

Net Income

NT$16.35 Million

TWD

Data as of

Mar 2026

Most recent filing

TaiMed Biologics Cash Flow Quality Index by Year (None–None)

TaiMed Biologics cash flow quality index by year from None to None. Year-by-year earnings quality comparison for TaiMed Biologics. For the full cash flow conversion analysis, see TaiMed Biologics (4147) cash conversion ratio.

Year	Quality Index	Operating CF (TWD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.